Michael W. Dunne Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael W. Dunne.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael W. Dunne. Michael W. Dunne is Director in Aviragen Therapeutics, Inc. ($NABI) and Chief Medical Officer in Durata Therapeutics, Inc. ($DRTX) and Chief Scientific Officer in Iterum Therapeutics plc ($ITRM) and Director in Iterum Therapeutics plc ($ITRM).
Latest Insider Trading Transactions of Michael W. Dunne
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DRTX, ITRM, VXRT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29 2021 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Director | Option Exercise | A | 0.00 | 10,494 | 0 | 10,494 | |
| Jan 27 2021 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Director | Sell | S | 1.73 | 33,143 | 57,337 | 256,355 | 289.5 K to 256.4 K (-11.45 %) |
| Jan 27 2021 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Director | Grant | A | 0.00 | 80,000 | 0 | 289,498 | 209.5 K to 289.5 K (+38.19 %) |
| Oct 28 2020 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Option Exercise | P | 0.65 | 46,155 | 30,001 | 46,155 | |
| Oct 28 2020 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Buy | P | 0.00 | 61,540 | 0 | 209,498 | 148 K to 209.5 K (+41.59 %) |
| Feb 19 2019 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Option Exercise | A | 5.80 | 85,000 | 493,000 | 85,000 | |
| Sep 06 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Buy | P | 10.00 | 500 | 5,000 | 147,958 | 147.5 K to 148 K (+0.34 %) |
| Aug 28 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Buy | P | 10.00 | 500 | 5,000 | 147,458 | 147 K to 147.5 K (+0.34 %) |
| Aug 28 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Buy | P | 10.00 | 500 | 5,000 | 146,958 | 146.5 K to 147 K (+0.34 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Option Exercise | C | 0.00 | 2,917 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Option Exercise | C | 0.00 | 4,050 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Option Exercise | C | 0.00 | 12,730 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Buy | P | 13.00 | 2,000 | 26,000 | 146,458 | 144.5 K to 146.5 K (+1.38 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Buy | C | 0.00 | 2,917 | 0 | 144,458 | 141.5 K to 144.5 K (+2.06 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Buy | C | 0.00 | 4,050 | 0 | 141,541 | 137.5 K to 141.5 K (+2.95 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Buy | C | 0.00 | 12,730 | 0 | 137,491 | 124.8 K to 137.5 K (+10.20 %) |
| May 29 2018 | ITRM | Iterum Therapeutic ... | Dunne Michael W. | Chief Scientific Of ... | Option Exercise | A | 13.00 | 79,567 | 1,034,371 | 79,567 | |
| May 22 2017 | AVIR | Aviragen Therapeut ... | Dunne Michael W. | Director | Option Exercise | A | 0.49 | 20,000 | 9,800 | 75,000 | |
| May 13 2016 | NABI | Aviragen Therapeut ... | Dunne Michael W. | Director | Option Exercise | A | 1.50 | 20,000 | 30,000 | 20,000 | |
| Oct 21 2015 | NABI | Aviragen Therapeut ... | Dunne Michael W. | Director | Option Exercise | A | 1.95 | 35,000 | 68,250 | 35,000 | |
| Jul 26 2012 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | C | 0.00 | 89,764 | 0 | 0 | |
| Jul 26 2012 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | P | 0.00 | 25,581 | 0 | 89,764 | |
| Jul 26 2012 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Buy | C | 0.00 | 11,220 | 0 | 11,220 | 0 to 11.2 K |
Page: 1